Stifel Financial Corp Novo Nordisk A S Transaction History

Stifel Financial Corp

$86.8 Billion
Q2 2024

A detailed history of Stifel Financial Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Stifel Financial Corp holds 1,772,032 shares of NVO stock, worth $214 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

1,772,032

Previous 1,697,316 4.4%

Holding current value

$214 Million

Previous $218 Million 16.06%

% of portfolio

0.29%

Previous 0.25%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $9.17 Million - $11 Million	74,716 Added 4.4%	1,772,032 $253 Million
Q1 2024 May 13, 2024	BUY	$102.11 - $135.92 $7.37 Million - $9.81 Million	72,189 Added 4.44%	1,697,316 $218 Million
Q4 2023 Feb 12, 2024	BUY	$87.78 - $105.45 $8.75 Million - $10.5 Million	99,677 Added 6.53%	1,625,127 $168 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $70.9 Million - $156 Million	780,110 Added 104.66%	1,525,450 $139 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $40.2 Million - $44.5 Million	-257,499 Reduced 25.68%	745,340 $121 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $27.3 Million - $32.9 Million	-206,573 Reduced 17.08%	1,002,839 $160 Million
Q4 2022 Feb 13, 2023	SELL	$102.55 - $135.33 $1.3 Million - $1.71 Million	-12,655 Reduced 1.04%	1,209,412 $164 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $1.69 Million - $2.08 Million	-17,778 Reduced 1.43%	1,222,067 $122 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $6.93 Million - $8.18 Million	67,162 Added 5.73%	1,239,845 $138 Million
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $12.1 Million - $14.6 Million	129,894 Added 12.46%	1,172,683 $130 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $2.88 Million - $3.51 Million	30,008 Added 2.96%	1,042,789 $117 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $3.56 Million - $4.5 Million	42,199 Added 4.35%	1,012,781 $97.2 Million
Q2 2021 Aug 13, 2021	BUY	$67.66 - $84.76 $2.39 Million - $3 Million	35,356 Added 3.78%	970,582 $81.3 Million
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $8.97 Million - $10.1 Million	133,799 Added 16.7%	935,226 $63.1 Million
Q4 2020 Feb 12, 2021	BUY	$63.89 - $73.8 $1.54 Million - $1.78 Million	24,125 Added 3.1%	801,427 $56 Million
Q3 2020 Nov 16, 2020	BUY	$63.69 - $70.22 $794,023 - $875,432	12,467 Added 1.63%	777,302 $54 Million
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $20.6 Million - $23.9 Million	352,407 Added 85.45%	764,835 $50.1 Million
Q1 2020 May 14, 2020	BUY	$49.46 - $64.78 $4.92 Million - $6.44 Million	99,394 Added 31.75%	412,428 $24.8 Million
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $1.51 Million - $1.76 Million	30,255 Added 10.7%	313,034 $18.1 Million
Q3 2019 Nov 19, 2019	SELL	$47.54 - $53.43 $8,889 - $9,991	-187 Reduced 0.07%	282,779 $14.6 Million
Q3 2019 Nov 13, 2019	BUY	$47.54 - $53.43 $1.29 Million - $1.45 Million	27,111 Added 10.6%	282,966 $14.6 Million
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $106,540 - $119,474	-2,277 Reduced 0.88%	255,855 $13.1 Million
Q1 2019 May 14, 2019	BUY	$46.36 - $52.63 $778,338 - $883,605	16,789 Added 6.96%	258,132 $13.5 Million
Q4 2018 Feb 13, 2019	SELL	$41.54 - $47.25 $2.63 Million - $3 Million	-63,415 Reduced 20.81%	241,343 $11.1 Million
Q3 2018 Nov 13, 2018	SELL	$46.76 - $51.24 $1.25 Million - $1.37 Million	-26,718 Reduced 8.06%	304,758 $14.4 Million
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $1.16 Million - $1.32 Million	-26,203 Reduced 7.33%	331,476 $15.3 Million
Q1 2018 May 11, 2018	SELL	$48.49 - $58.14 $286,187 - $343,142	-5,902 Reduced 1.62%	357,679 $17.6 Million
Q4 2017 Feb 14, 2018	BUY	$47.53 - $53.73 $113,263 - $128,038	2,383 Added 0.66%	363,581 $19.5 Million
Q3 2017 Nov 13, 2017	BUY	$41.15 - $49.22 $14.9 Million - $17.8 Million	361,198	361,198 $0

Others Institutions Holding NVO

# of Institutions

1,991

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $273B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Novo Nordisk A S Transaction History